期刊文献+

高血压病患者不同左室构型与胰岛素抵抗的相关性 被引量:3

Relationship of Left Ventricular Geometry and Insulin Resistance in Essential Hypertension
原文传递
导出
摘要 目的探讨高血压患者胰岛素抵抗对左室构型的影响。方法对高血压组164例进行常规心脏超声、空腹葡萄糖(FBG)、空腹胰岛素(FIN)、血脂检查。采用胰岛素敏感指数(HOMA-IR)作为评价胰岛素抵抗指标,按Gnanu分类法将高血压组划分为正常构型、向心性重构组、向心性肥厚组和离心性肥厚组。采用组间比较、相关性分析等统计学方法进行评价。结果高血压患者按左室重量指数(LVMI)分组,两组间空腹胰岛素及胰岛素抵抗差异无统计学意义(P>0.05);但按相对室壁厚度(RWT)分组,空腹胰岛素及胰岛素抵抗差异具有统计学意义(P<0.05)。并且向心性重构组和向心性肥厚组明显高于正常构型组(P<0.05),而离心性肥厚组与正常构型组比较差异无统计学意义(P>0.05)。逐步回归分析显示LVMI与体重指数、收缩压和舒张压呈正相关(P<0.05~P<0.01),RWT与HOMA-IR呈负相关(P<0.05)。结论胰岛素抵抗可能是高血压患者合并左室肥厚的重要影响因素之一,改善胰岛素抵抗有利于高血压患者左室肥厚的防治。 Objective To investigate the effect of insulin resistance on left ventricle geometry.Methods Echocardiography,fasting serum glucose,fasting serum insulin and blood lipids were measured and the insulin sensitivity was calculated in 164 patients with essential hypertension.A total of 164 patients with essential hypertension were divided into normal geometry group,concentric remodeling group,concentric hypertrophy group and eccentric hypertrophy group.The corresponding data were compared by means of statistic among the groups.Results According to left ventricular mass index(LVMI),there was no difference in the fasting serum glucose and the insulin resistance(P〉0.05).According to relative wall thickness(RWT),there were considerable differences in the fasting serum glucose and the insulin resistance(P〈0.05).The normal geometry group,the fasting serum glucose and the insulin resistance in the concentric remodeling group and concentric hypertrophy group were higher(P〈0.05).There was no difference in eccentric hypertrophy group(P〉0.05).Multiple stepwise regression analysis showed that LVMI was positively correlated with body mass index(BMI),systolic blood pressure and diastolic blood pressure(P〈0.05~P 〈0.01),only HOMA-IR was independently correlated with RWT(P〈0.05).Conclusion Insulin resistance may play an important role in the left ventricular hypertrophy of essential hypertension.It is helpful in the prevention and the cure of left ventricular hypertrophy of essential hypertension by improving insulin resistance.
出处 《热带医学杂志》 CAS 2010年第7期830-832,888,共4页 Journal of Tropical Medicine
基金 广东省医学科研基金(No.A2009343)
关键词 高血压病 左室重构 左室构型 胰岛素抵抗 hypertension left ventricle remodeling left ventricular geometry insulin resistance
  • 相关文献

参考文献8

  • 1Araki K, Masaki T, Katsuragi I, et al. Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice [J]. Hypertension, 2006, 48(1): 51-57. 被引量:1
  • 2Benndorf RA, Rudolph T, Appel D, et al. Telmisartan improues insulin sensitivity in nondiabetic patients with essential hypertension [J~. Metabolism, 2006, 55(9): 1159-1164. 被引量:1
  • 3Miyazato J, Horio T, Takishita S, et al. Fasting plasma glucose is an independent determinant of left ventricular diastolic dysfunction in nondiabetie patients with treated essential hypertension [J]. Hypertens Res, 2002, 25 (3) : 403 -409. 被引量:1
  • 4Jansen PM, Danser AH, Imholz BP, et al. Aldosterone- receptor antogohism in hypertension[J]. J Hypertens, 2009, 27(4) : 680-691. 被引量:1
  • 5孙丽侠,吴伟.胰岛素抵抗对高血压左心室肥厚的影响[J].海南医学,2008,19(8):4-6. 被引量:3
  • 6贺利平,赵兴胜,吴云.高血压左室肥厚与三种血管活性因子水平的相关性研究[J].中国心血管病研究,2008,6(5):346-348. 被引量:4
  • 7Sundstrom J, Lind L, Nystrom N, et al. Left ventricular concentric remodeling rather than left ventrieular hypertrophy is related to insulin resistance syndrone in eldly mem [J]. Circulation, 2000, 101(22): 2595-2600. 被引量:1
  • 8王若琦,席波,李天资,蓝景生,陆克兴,潘兴寿,谭志辉,潘征,黄显南,黄照河.原发性高血压患者胰岛β细胞功能和胰岛素抵抗研究[J].临床心血管病杂志,2010,26(3):196-198. 被引量:11

二级参考文献29

  • 1全国高血压,冠心病与糖尿病专题研讨会纪要[J].中华心血管病杂志,1993,21(5):260-265. 被引量:105
  • 2何玲,万国华,李拥军.醛固酮在高血压血管重塑和靶器官损害中的作用[J].临床荟萃,2005,20(11):655-657. 被引量:4
  • 3MANCIA G. The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction[J]. Acta Diabetol, 2005, 42: S17-25. 被引量:1
  • 4MANCIA G, DE BACKER G,DOMINICZAK A, et al. 2007 Guidelines for the management of arterial hypertension.. The Task Foi'ce for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European, Society of Cardiology (ESC)[J]. Eur Heart J,2007,28: 1462- 1536. 被引量:1
  • 5VASOVIC O,ZAMAKLAR M,LALIC K, et al. The prevalence of hypertension and microalbuminuria in diabetes mellitus type 1 and type 2[J].Srp Arh Celok Lek, 2005,133:229-232. 被引量:1
  • 6QIAO Q, JOUSILAHTI P, ERIKSSON J,et al. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up[J]. Diabetes Care, 2003,26 : 2910 - 2914. 被引量:1
  • 7ECKEL R H, GRUNDY S M, ZIMMET P Z. The metabolic syndrome[J].Lancet, 2005, 365: 1415-1428. 被引量:1
  • 8GROOP L C. Insulin resistance:the fundamental trigger of type 2 diabetes[J].Diabetes Obes Metab, 1999,1(Suppl 1) :S1-7. 被引量:1
  • 9LI Y B, XU W, LIAO Z H, et al. Induction of long- term glycemic control in newly diagnosed type 2 dia- betic patients is associated with improvement of βcell function[J]. Diabetes Care, 2004, 27 : 2597-2602. 被引量:1
  • 10WHO consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 : diagnosis and classification of diabetes mellitus[S]. Geneva : World Health Organisation, 1999. 被引量:1

共引文献15

同被引文献42

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部